Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

Download Mobile App




All-In-One CLIA Analyzer to Transform Clinical Diagnostics Landscape

By LabMedica International staff writers
Posted on 12 Jul 2023

An automated, compact, and cost-effective CLIA analyzer combines cutting-edge technology with versatile capabilities to provide a wide range of qualitative and quantitative testing options for analytes in human serum, plasma, whole blood, and urine samples. More...

Anbio Biotechnology (Frankfurt, Germany) has launched the Anbio ADL i1910 all-in-one CLIA analyzer that employs a direct chemiluminescence method based on acridinium ester. This ensures accurate and consistent results across a wide range of applications, including hormone detection, myocardial disease screening, infectious disease diagnostics, or tumor-related antigen analysis. The ADL i1910 delivers a powerful performance and fulfills the varied requirements of modern healthcare professionals. It offers an impressive range of 49 developed assays, enabling qualitative as well as quantitative testing of analytes. The ADL i1910 provides a comprehensive immunodiagnostic solution for healthcare providers to access vital information in an efficient manner.

The ADL i1910 significantly enhances laboratory productivity, thanks to its high throughput of up to 120 tests per hour. With its quick turnaround times, healthcare providers can arrive at timely and informed decisions, eventually improving patient care. Its intuitive graphic user interface coupled with a large color touch screen simplifies operation and shortens the learning curve. It user-friendly design makes it easy to use for experienced professionals and new users alike, thus improving overall efficiency. Designed to occupy minimal space, the ADL i1910 has a small footprint in order to optimize valuable space for other necessary lab equipment, making it ideal for laboratories of all sizes. By offering healthcare providers a cost-effective and comprehensive solution, the Anbio ADL i1910 is expected to transform the clinical diagnostics space.

"Anbio is proud to introduce the ADL i1910, a breakthrough CLIA analyzer that revolutionizes clinical diagnostics," said Jack Davis, Chief Business Officer at Anbio. "With its advanced technology, extensive assay menu, and impressive throughput, the ADL i1910 provides healthcare professionals with a reliable and efficient solution for a wide range of diagnostic applications."

Related Links:
Anbio Biotechnology 


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
New
Alzheimer's Disease Biomarker Assay
Elecsys Phospho-Tau (217P) Plasma
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

AI in Cancer Diagnosis and Molecular Testing Takes Center Stage at AMP 2026

Artificial intelligence (AI) is increasingly being integrated into molecular diagnostics, offering new approaches to interpreting complex genetic information, classifying cancers, and optimizing laboratory testing.... Read more

Microbiology

view channel
Image: Graphical Abstract (Matthew A Butzler, Jennifer L Reed, Alaina M Olson, et al. Development of a Rapid Automated Point-of-Care Test for Mycobacterium tuberculosis Detection from Tongue Swabs and Sputum Specimens on the DASH® Rapid PCR System, Open Forum Infectious Diseases, 2026; https://doi.org/10.1093/ofid/ofag706)

Rapid Point-of-Care Test Detects Tuberculosis from Tongue Swab and Sputum

Tuberculosis remains a major infectious disease challenge, particularly in regions with limited access to diagnostic testing and treatment. Diagnosis can be time-consuming, and collecting sputum samples... Read more

Pathology

view channel
Image Credit: Adobe Stock

New Training Approach Helps AI Distinguish Neighboring Cells in Tissue

Artificial intelligence (AI) can assist with identifying cells in digital pathology images, but densely packed tissue remains difficult to analyze. Neighboring cells may be merged, counted twice, or missed,... Read more

Industry

view channel
Image: The TOMR trial uses Signatera-guided MRD testing to identify high-risk patients for curative-intent treatment.

Natera and Incyte Collaborate on MRD-Guided Colorectal Cancer Treatment Study

Natera (Austin, TX, USA) has entered into a clinical collaboration with Incyte (Wilmington, DE, USA) for a Phase II study evaluating molecular residual disease (MRD)-guided treatment in colorectal cancer.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.